S&P・Nasdaq 本質的価値 お問い合わせ

Biodexa Pharmaceuticals Plc BDRX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • GB • USD

SharesGrow Score
27/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Biodexa Pharmaceuticals Plc (BDRX) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

アナリスト予想 一株当たり利益(EPS) $-0.01 および 売上高 $0.00B 来期予想.

一株当たり利益(EPS)実績推移: 2024: 実績 $-1,157,000.00 vs 予想 $-0.01 (下回る -22051452017.7%). アナリスト精度: 0%.

EPS予測 — BDRX

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$1,157,000.00 vs Est –$0.01 ▼ 100.0% off
2025 Actual $0.00 vs Est –$0.00 ▲ 0.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS trend is improving.

売上高予測 — BDRX

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る